|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ung L, Lam AK, Morris DL and Chua TC:
Tissue-based biomarkers predicting outcomes in metastatic
colorectal cancer: A review. Clin Transl Oncol. 16:425–435. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meijer HA, Kong YW, Lu WT, Wilczynska A,
Spriggs RV, Robinson SW, Godfrey JD, Willis AE and Bushell M:
Translational repression and eIF4A2 activity are critical for
microRNA-mediated gene regulation. Science. 340:82–85. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu J, Zou Z, Nie P, Kou X, Wu B, Wang S,
Song Z and He J: Downregulation of microRNA-27b-3p enhances
tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1
expression. Cell Death Dis. 7:e24542016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ao X, Nie P, Wu B, Xu W, Zhang T, Wang S,
Chang H and Zou Z: Decreased expression of microRNA-17 and
microRNA-20b promotes breast cancer resistance to taxol therapy by
upregulation of NCOA3. Cell Death Dis. 7:e24632016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rokavec M, Li H, Jiang L and Hermeking H:
The p53/miR-34 axis in development and disease. J Mol Cell Biol.
6:214–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slabáková E, Culig Z, Remšík J and Souček
K: Alternative mechanisms of miR-34a regulation in cancer. Cell
Death Dis. 8:e31002017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang X, Ai F, Li X, Tian L, Wang X, Shen
S and Liu F: MicroRNA-34a suppresses colorectal cancer metastasis
by regulating Notch signaling. Oncol Lett. 14:2325–2333. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue
YF, Li G, Lu X, Sun Z and Tang KF: MicroRNA-34a inhibits migration
and invasion of colon cancer cells via targeting to Fra-1.
Carcinogenesis. 33:519–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li L, Yuan L, Luo J, Gao J, Guo J and Xie
X: MiR-34a inhibits proliferation and migration of breast cancer
through down-regulation of Bcl-2 and SIRT1. Clin Exp Med.
13:109–117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Franchina T, Amodeo V, Bronte G, Savio G,
Ricciardi GR, Picciotto M, Russo A, Giordano A and Adamo V:
Circulating miR-22, miR-24 and miR-34a as novel predictive
biomarkers to pemetrexed-based chemotherapy in advanced non-small
cell lung cancer. J Cell Physiol. 229:97–99. 2014.PubMed/NCBI
|
|
18
|
Cao W, Yang W, Fan R, Li H, Jiang J, Geng
M, Jin Y and Wu Y: miR-34a regulates cisplatin-induce gastric
cancer cell death by modulating PI3K/AKT/survivin pathway. Tumour
Biol. 35:1287–1295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nugent M, Miller N and Kerin MJ:
Circulating miR-34a levels are reduced in colorectal cancer. J Surg
Oncol. 106:947–952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li
Y, Li Z, Ng SS, Sung JJ, et al: miR-34a-5p suppresses colorectal
cancer metastasis and predicts recurrence in patients with stage
II/III colorectal cancer. Oncogene. 34:4142–4152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu C, Rangnekar VM, Adamson E and Mercola
D: Suppression of growth and transformation and induction of
apoptosis by EGR-1. Cancer Gene Ther. 5:3–28. 1998.PubMed/NCBI
|
|
23
|
Calogero A, Arcella A, De Gregorio G,
Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G,
Gagliardi FM, et al: The early growth response gene EGR-1 behaves
as a suppressor gene that is down-regulated independent of ARF/Mdm2
but not p53 alterations in fresh human gliomas. Clin Cancer Res.
7:2788–2796. 2001.PubMed/NCBI
|
|
24
|
Levin WJ, Press MF, Gaynor RB, Sukhatme
VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM and
Slamon DJ: Expression patterns of immediate early transcription
factors in human non-small cell lung cancer. The Lung Cancer Study
Group. Oncogene. 11:1261–1269. 1995.PubMed/NCBI
|
|
25
|
Ahmed MM: Regulation of radiation-induced
apoptosis by early growth response-1 gene in solid tumors. Curr
Cancer Drug Targets. 4:43–52. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baron V, Adamson ED, Calogero A, Ragona G
and Mercola D: The transcription factor Egr1 is a direct regulator
of multiple tumor suppressors including TGFbeta1, PTEN, p53, and
fibronectin. Cancer Gene Ther. 13:115–124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Virolle T, Adamson ED, Baron V, Birle D,
Mercola D, Mustelin T and de Belle I: The Egr-1 transcription
factor directly activates PTEN during irradiation-induced
signalling. Nat Cell Biol. 3:1124–1128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Krones-Herzig A, Adamson E and Mercola D:
Early growth response 1 protein, an upstream gatekeeper of the p53
tumor suppressor, controls replicative senescence. Proc Natl Acad
Sci USA. 100:3233–3238. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SO, Kwon JI, Jeong YK, Kim GY, Kim ND
and Choi YH: Induction of Egr-1 is associated with anti-metastatic
and anti-invasive ability of beta-lapachone in human
hepatocarcinoma cells. Biosci Biotechnol Biochem. 71:2169–2176.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Katsumoto T, Mitsushima A and Kurimura T:
The role of the vimentin intermediate filaments in rat 3Y1 cells
elucidated by immunoelectron microscopy and computer-graphic
reconstruction. Biol Cell. 68:139–146. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McInroy L and Maatta A: Down-regulation of
vimentin expression inhibits carcinoma cell migration and adhesion.
Biochem Biophys Res Commun. 360:109–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bargagna-Mohan P, Hamza A, Kim YE, Khuan
Abby Ho Y, Mor-Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz
DM, Zhan CG, et al: The tumor inhibitor and antiangiogenic agent
withaferin A targets the intermediate filament protein vimentin.
Chem Biol. 14:623–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wrighton KH: Cell migration: EMT promotes
contact inhibition of locomotion. Nat Rev Mol Cell Biol.
16:5182015. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiao S, Liu L, Lu X, Long J, Zhou X and
Fang M: The prognostic significance of bromodomain PHD-finger
transcription factor in colorectal carcinoma and association with
vimentin and E-cadherin. J Cancer Res Clin. 141:1465–1474. 2015.
View Article : Google Scholar
|
|
38
|
Toiyama Y, Yasuda H, Saigusa S, Tanaka K,
Inoue Y, Goel A and Kusunoki M: Increased expression of Slug and
Vimentin as novel predictive biomarkers for lymph node metastasis
and poor prognosis in colorectal cancer. Carcinogenesis.
34:2548–2557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View
Article : Google Scholar : PubMed/NCBI
|
